Arrowhead Pharmaceuticals (ARWR) Divestments (2010)

Arrowhead Pharmaceuticals' (ARWR) quarterly Divestments came in at $57593.0 in Q3 2010.

Arrowhead Pharmaceuticals (ARWR) Divestments (2010) Analysis & Trends

Arrowhead Pharmaceuticals (ARWR) has 1 years of Divestments data on file, last reported at $57593.0 in Q3 2010.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Divestments (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn -
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn -
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 9.82 Mn
7 Royalty Pharma 33.72 Bn 35.84 Bn - -13.21 Mn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn -
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -
10 Arrowhead Pharmaceuticals 12.23 Bn 10.63 Bn - -

Historic Data

Download Data
DateValue
Sep 30, 2010 57,593.00